Skip to content

Drug interactions

Brigatinib + Ifosfamide

Severity: Minor

Brigatinib and Ifosfamide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Brigatinib is a weak CYP3A4 inducer in vitro and might modestly increase ifosfamide metabolism, raising formation of toxic chloroacetaldehyde. Clinical significance is uncertain and is based on prediction rather than direct study.

What this interaction means in plain words

Brigatinib and Ifosfamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Brigatinib belongs to Oncology; Ifosfamide belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 induction by brigatinib increasing ifosfamide metabolism.

What to do

No routine change is needed. Watch for neurotoxicity and renal dysfunction during ifosfamide cycles.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brigatinib and Ifosfamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brigatinib with Ifosfamide?

MediHelp rates the interaction as minor. Brigatinib and Ifosfamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Brigatinib is a weak CYP3A4 inducer in vitro and might modestly increase ifosfamide metabolism, raising formation of toxic chloroacetaldehyde. Clinical significance is uncertain and is based on prediction rather than direct study.

How serious is the interaction between Brigatinib and Ifosfamide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Watch for neurotoxicity and renal dysfunction during ifosfamide cycles.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in